mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
-0.11 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.16 |
0.3 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.3 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.3 |